{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:53:58Z","timestamp":1768704838763,"version":"3.49.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04004-5","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:57:46Z","timestamp":1740067066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the shared genetic mechanisms of atopic dermatitis and alopecia areata via bioinformatics approaches"],"prefix":"10.1007","volume":"317","author":[{"given":"Qianqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"4004_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084130","author":"J Sroka-Tomaszewska","year":"2021","unstructured":"Sroka-Tomaszewska J, Trzeciak M (2021) Molecular mechanisms of atopic Dermatitis Pathogenesis. Int J Mol Sci 22(8). https:\/\/doi.org\/10.3390\/ijms22084130","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4004_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S St\u00e4nder","year":"2021","unstructured":"St\u00e4nder S (2021) Atopic dermatitis. N Engl J Med 384(12):1136\u20131143. https:\/\/doi.org\/10.1056\/NEJMra2023911","journal-title":"N Engl J Med"},{"issue":"5","key":"4004_CR3","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","volume":"151","author":"AC Schuler CFt, Billi","year":"2023","unstructured":"Schuler CFt, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE (2023) Novel insights into atopic dermatitis. J Allergy Clin Immunol 151(5):1145\u20131154. https:\/\/doi.org\/10.1016\/j.jaci.2022.10.023","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"4004_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H, Zhang Z, Zhang H, Guo Y, Yao Z (2021) Update on the Pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol 61(3):324\u2013338. https:\/\/doi.org\/10.1007\/s12016-021-08880-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"4004_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","volume":"148","author":"R Chovatiya","year":"2021","unstructured":"Chovatiya R, Paller AS (2021) JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol 148(4):927\u2013940. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.009","journal-title":"J Allergy Clin Immunol"},{"issue":"10247","key":"4004_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet (London England) 396(10247):345\u2013360. https:\/\/doi.org\/10.1016\/s0140-6736(20)31286-1","journal-title":"Lancet (London England)"},{"key":"4004_CR7","doi-asserted-by":"publisher","unstructured":"Bawany F, Northcott CA, Beck LA, Pigeon WR (2021) Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies. The journal of allergy and clinical immunology In practice.9(4):1488\u20131500.https:\/\/doi.org\/10.1016\/j.jaip.2020.12.007","DOI":"10.1016\/j.jaip.2020.12.007"},{"key":"4004_CR8","doi-asserted-by":"publisher","unstructured":"Chang YS, Chiang BL (2018) Sleep disorders and atopic dermatitis: a 2-way street? The Journal of allergy and clinical immunology. 142(4):1033\u20131040. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.005","DOI":"10.1016\/j.jaci.2018.08.005"},{"issue":"3","key":"4004_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jdv.19518","volume":"38","author":"J Wan","year":"2024","unstructured":"Wan J, Wang S, Shin DB et al (2024) Neuropsychiatric disorders in adults with atopic dermatitis: a population-based cohort study. J Eur Acad Dermatology Venereology: JEADV 38(3):543\u2013548. https:\/\/doi.org\/10.1111\/jdv.19518","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"2","key":"4004_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1164\/rccm.202205-0951OC","volume":"207","author":"K Ahn","year":"2023","unstructured":"Ahn K, Penn RB, Rattan S, Panettieri RA Jr., Voight BF, An SS (2023) Mendelian randomization analysis reveals a Complex Genetic interplay among atopic dermatitis, Asthma, and gastroesophageal reflux disease. Am J Respir Crit Care Med 207(2):130\u2013137. https:\/\/doi.org\/10.1164\/rccm.202205-0951OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4004_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Annals of allergy, Asthma & immunology: official publication of the American College of Allergy. Asthma Immunol 123(2):144\u2013151. https:\/\/doi.org\/10.1016\/j.anai.2019.04.020","journal-title":"Asthma Immunol"},{"issue":"3","key":"4004_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2023.10.031","volume":"90","author":"MJ Diaz","year":"2024","unstructured":"Diaz MJ, Haq Z, Abdi P, Tran JT, Guttman-Yassky E, Ungar B (2024) Association between Alopecia Areata and atopic dermatitis: a nested case-control study of the all of us database. J Am Acad Dermatol 90(3):607\u2013609. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.031","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4004_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/all.15071","volume":"77","author":"E Guttman-Yassky","year":"2022","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Bares J et al (2022) Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for Alopecia Areata patients. Allergy 77(3):897\u2013906. https:\/\/doi.org\/10.1111\/all.15071","journal-title":"Allergy"},{"key":"4004_CR14","doi-asserted-by":"publisher","unstructured":"Kageyama R, Ito T, Hanai S et al (2021) Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata. Int J Mol Sci.22(5)https:\/\/doi.org\/10.3390\/ijms22052618","DOI":"10.3390\/ijms22052618"},{"issue":"3","key":"4004_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","volume":"61","author":"C Zhou","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J (2021) Alopecia Areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol 61(3):403\u2013423. https:\/\/doi.org\/10.1007\/s12016-021-08883-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"4004_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148359","author":"W Xu","year":"2023","unstructured":"Xu W, Wan S, Xie B, Song X (2023) Novel potential therapeutic targets of Alopecia Areata. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1148359","journal-title":"Front Immunol"},{"key":"4004_CR17","doi-asserted-by":"publisher","unstructured":"Gaurav A, Eang B, Mostaghimi A (2024) Alopecia Areata. JAMA Dermatology 160(3). https:\/\/doi.org\/10.1001\/jamadermatol.2023.4661","DOI":"10.1001\/jamadermatol.2023.4661"},{"issue":"1","key":"4004_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaad.2020.06.047","volume":"85","author":"A Toussi","year":"2021","unstructured":"Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M (2021) Psychosocial and psychiatric comorbidities and health-related quality of life in Alopecia Areata: a systematic review. J Am Acad Dermatol 85(1):162\u2013175. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.047","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4004_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjd.14497","volume":"175","author":"F Rencz","year":"2016","unstructured":"Rencz F, Gul\u00e1csi L, P\u00e9ntek M, Wikonk\u00e1l N, Baji P, Brodszky V (2016) Alopecia Areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol 175(3):561\u2013571. https:\/\/doi.org\/10.1111\/bjd.14497","journal-title":"Br J Dermatol"},{"issue":"5","key":"4004_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jaad.2019.05.086","volume":"88","author":"JP Okhovat","year":"2023","unstructured":"Okhovat JP, Marks DH, Manatis-Lornell A, Hagigeorges D, Locascio JJ, Senna MM (2023) Association between Alopecia Areata, anxiety, and depression: a systematic review and meta-analysis. J Am Acad Dermatol 88(5):1040\u20131050. https:\/\/doi.org\/10.1016\/j.jaad.2019.05.086","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"4004_CR21","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jaci.2019.08.035","volume":"144","author":"A Gilhar","year":"2019","unstructured":"Gilhar A, Laufer-Britva R, Keren A, Paus R (2019) Frontiers in Alopecia Areata pathobiology research. J Allergy Clin Immunol 144(6):1478\u20131489. https:\/\/doi.org\/10.1016\/j.jaci.2019.08.035","journal-title":"J Allergy Clin Immunol"},{"key":"4004_CR22","doi-asserted-by":"publisher","unstructured":"Chen Y, Griffiths CEM, Bulfone-Paus S (2023) Exploring mast Cell-CD8 T cell interactions in inflammatory skin diseases. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24021564","DOI":"10.3390\/ijms24021564"},{"issue":"19","key":"4004_CR23","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian Randomization. Jama. 318(19):1925\u20131926. https:\/\/doi.org\/10.1001\/jama.2017.17219","journal-title":"Jama"},{"key":"4004_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical Res ed). https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ (Clinical Res ed)"},{"issue":"3","key":"4004_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jaad.2023.05.023","volume":"89","author":"R O\u2019Hagan","year":"2023","unstructured":"O\u2019Hagan R, Caldas SA, Correa da Rosa JM, Guttman-Yassky E, Ungar B (2023) The impact of atopic dermatitis on Alopecia Areata: a 2-sample mendelian randomization study. J Am Acad Dermatol 89(3):600\u2013602. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.023","journal-title":"J Am Acad Dermatol"},{"key":"4004_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1132719","author":"W Zhou","year":"2023","unstructured":"Zhou W, Cai J, Li Z, Lin Y (2023) Association of atopic dermatitis with autoimmune diseases: a bidirectional and multivariable two-sample mendelian randomization study. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1132719","journal-title":"Front Immunol"},{"key":"4004_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1388047","author":"R You","year":"2024","unstructured":"You R, Duan J, Zhou Y et al (2024) The causal effects of inflammatory and autoimmune skin diseases on thyroid diseases: evidence from mendelian randomization study. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2024.1388047","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"22","key":"4004_CR28","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/bioinformatics\/btq562","volume":"26","author":"J Montojo","year":"2010","unstructured":"Montojo J, Zuberi K, Rodriguez H et al (2010) GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinf (Oxford England) 26(22):2927\u20132928. https:\/\/doi.org\/10.1093\/bioinformatics\/btq562","journal-title":"Bioinf (Oxford England)"},{"issue":"3","key":"4004_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","volume":"75","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Gadkari A, Worm M et al (2016) Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). J Am Acad Dermatol 75(3):506\u2013515. https:\/\/doi.org\/10.1016\/j.jaad.2016.04.054","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4004_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","volume":"371","author":"LA Beck","year":"2014","unstructured":"Beck LA, Tha\u00e7i D, Hamilton JD et al (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371(2):130\u2013139. https:\/\/doi.org\/10.1056\/NEJMoa1314768","journal-title":"N Engl J Med"},{"issue":"10086","key":"4004_CR31","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/s0140-6736(17)31191-1","volume":"389","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, de Bruin-Weller M, Gooderham M et al (2017) Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet (London England) 389(10086):2287\u20132303. https:\/\/doi.org\/10.1016\/s0140-6736(17)31191-1","journal-title":"Lancet (London England)"},{"issue":"1","key":"4004_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","volume":"118","author":"T Zuberbier","year":"2006","unstructured":"Zuberbier T, Orlow SJ, Paller AS et al (2006) Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 118(1):226\u2013232. https:\/\/doi.org\/10.1016\/j.jaci.2006.02.031","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4004_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","volume":"89","author":"R Sidbury","year":"2023","unstructured":"Sidbury R, Alikhan A, Bercovitch L et al (2023) Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol 89(1):e1\u2013e20. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.029","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4004_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1684\/ejd.2011.1560","volume":"22","author":"A Torrelo","year":"2012","unstructured":"Torrelo A, Ortiz J, Alomar A, Ros S, Prieto M, Cuervo J (2012) Atopic dermatitis: impact on quality of life and patients\u2019 attitudes toward its management. Eur J Dermatology: EJD 22(1):97\u2013105. https:\/\/doi.org\/10.1684\/ejd.2011.1560","journal-title":"Eur J Dermatology: EJD"},{"issue":"1","key":"4004_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","volume":"15","author":"NA Gandhi","year":"2016","unstructured":"Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD (2016) Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discovery 15(1):35\u201350. https:\/\/doi.org\/10.1038\/nrd4624","journal-title":"Nat Rev Drug Discovery"},{"key":"4004_CR36","doi-asserted-by":"publisher","unstructured":"Weidinger S, Novak N (2016) Atopic dermatitis. Lancet (London, England). 387. 100231109\u20131122. https:\/\/doi.org\/10.1016\/s0140-6736(15)00149-x","DOI":"10.1016\/s0140-6736(15)00149-x"},{"issue":"4","key":"4004_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaci.2014.08.008","volume":"134","author":"DY Leung","year":"2014","unstructured":"Leung DY, Guttman-Yassky E (2014) Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 134(4):769\u2013779. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.008","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"4004_CR38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","volume":"127","author":"M Su\u00e1rez-Fari\u00f1as","year":"2011","unstructured":"Su\u00e1rez-Fari\u00f1as M, Tintle SJ, Shemer A et al (2011) Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 127(4):954\u2013964. https:\/\/doi.org\/10.1016\/j.jaci.2010.12.1124","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"4004_CR39","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","volume":"130","author":"JK Gittler","year":"2012","unstructured":"Gittler JK, Shemer A, Su\u00e1rez-Fari\u00f1as M et al (2012) Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130(6):1344\u20131354. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.012","journal-title":"J Allergy Clin Immunol"},{"key":"4004_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00353","author":"T Biedermann","year":"2015","unstructured":"Biedermann T, Skabytska Y, Kaesler S, Volz T (2015) Regulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2015.00353","journal-title":"Front Immunol"},{"key":"4004_CR41","doi-asserted-by":"publisher","unstructured":"Rerknimitr P, Otsuka A, Nakashima C, Kabashima K (2017) The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. https:\/\/doi.org\/10.1186\/s41232-017-0044-7. Inflamm Regen.37:14.","DOI":"10.1186\/s41232-017-0044-7"},{"issue":"3","key":"4004_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jaci.2022.03.030","volume":"150","author":"S de Lusignan","year":"2022","unstructured":"de Lusignan S, Alexander H, Broderick C et al (2022) Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. J Allergy Clin Immunol 150(3):709\u2013713. https:\/\/doi.org\/10.1016\/j.jaci.2022.03.030","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"4004_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaad.2018.09.025","volume":"80","author":"S Narla","year":"2019","unstructured":"Narla S, Silverberg JI (2019) Association between atopic dermatitis and autoimmune disorders in US adults and children: a cross-sectional study. J Am Acad Dermatol 80(2):382\u2013389. https:\/\/doi.org\/10.1016\/j.jaad.2018.09.025","journal-title":"J Am Acad Dermatol"},{"key":"4004_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19044","author":"W Chen","year":"2023","unstructured":"Chen W, Li S, Cai X et al (2023) Association between Alopecia Areata and atopic dermatitis: current evidence. J Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.19044","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"4004_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1089\/derm.2023.0114","volume":"35","author":"R Sun","year":"2024","unstructured":"Sun R, Kong D (2024) Bilateral Association between atopic Dermatitis\u00ae and Alopecia Areata: a systematic review and Meta-analysis. Dermatitis 35(3):208\u2013218. https:\/\/doi.org\/10.1089\/derm.2023.0114","journal-title":"Dermatitis"},{"issue":"2","key":"4004_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/bjd.19624","volume":"185","author":"LU Ivert","year":"2021","unstructured":"Ivert LU, Wahlgren CF, Lindel\u00f6f B, Dal H, Bradley M, Johansson EK (2021) Association between atopic dermatitis and autoimmune diseases: a population-based case-control study. Br J Dermatol 185(2):335\u2013342. https:\/\/doi.org\/10.1111\/bjd.19624","journal-title":"Br J Dermatol"},{"issue":"2","key":"4004_CR47","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1111\/ajd.13208","volume":"61","author":"J Magdaleno-Tapial","year":"2020","unstructured":"Magdaleno-Tapial J, Valenzuela-O\u00f1ate C, Garc\u00eda-Legaz-Mart\u00ednez M, Mart\u00ednez-Domenech \u00c1, P\u00e9rez-Ferriols A (2020) Improvement of Alopecia Areata with Dupilumab in a patient with severe atopic dermatitis and review the literature. Australas J Dermatol 61(2):e223\u2013e225. https:\/\/doi.org\/10.1111\/ajd.13208","journal-title":"Australas J Dermatol"},{"issue":"6","key":"4004_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.18176\/jiaci.0301","volume":"28","author":"B Barroso-Garc\u00eda","year":"2018","unstructured":"Barroso-Garc\u00eda B, Rial MJ, Molina A, Sastre J (2018) Alopecia Areata in severe atopic dermatitis treated with Dupilumab. J Investigat Allergol Clin Immunol 28(6):420\u2013421. https:\/\/doi.org\/10.18176\/jiaci.0301","journal-title":"J Investigat Allergol Clin Immunol"},{"issue":"3","key":"4004_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/ced\/llac088","volume":"48","author":"O McFeely","year":"2023","unstructured":"McFeely O, Blasco MC, Doyle C et al (2023) I feel like a new woman\u2019: atopic dermatitis and alopecia areata treated successfully by dupilumab. Clin Exp Dermatol 48(3):266\u2013267. https:\/\/doi.org\/10.1093\/ced\/llac088","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"4004_CR50","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/ddg.13990","volume":"17","author":"L Ludriksone","year":"2019","unstructured":"Ludriksone L, Elsner P, Schliemann S (2019) Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients. J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG 17(12):1278\u20131280. https:\/\/doi.org\/10.1111\/ddg.13990","journal-title":"J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG"},{"issue":"2","key":"4004_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bjd.18976","volume":"183","author":"K Harada","year":"2020","unstructured":"Harada K, Irisawa R, Ito T, Uchiyama M, Tsuboi R (2020) The effectiveness of dupilumab in patients with Alopecia Areata who have atopic dermatitis: a case series of seven patients. Br J Dermatol 183(2):396\u2013397. https:\/\/doi.org\/10.1111\/bjd.18976","journal-title":"Br J Dermatol"},{"key":"4004_CR52","doi-asserted-by":"publisher","unstructured":"Minokawa Y, Sawada Y, Nakamura M (2022) Lifestyle factors involved in the pathogenesis of Alopecia Areata. Int J Mol Sci 23(3). https:\/\/doi.org\/10.3390\/ijms23031038","DOI":"10.3390\/ijms23031038"},{"issue":"7","key":"4004_CR53","doi-asserted-by":"publisher","first-page":"103339","DOI":"10.1016\/j.autrev.2023.103339","volume":"22","author":"H Zaaroura","year":"2023","unstructured":"Zaaroura H, Gilding AJ, Sibbald C (2023) Biomarkers in Alopecia Areata: a systematic review and meta-analysis. Autoimmun rev 22(7):103339. https:\/\/doi.org\/10.1016\/j.autrev.2023.103339","journal-title":"Autoimmun rev"},{"issue":"1","key":"4004_CR54","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jisp.2020.04.008","volume":"20","author":"DH Marks","year":"2020","unstructured":"Marks DH, Senna MM (2020) A potential role for IL-4 and IL-13 in an Alopecia Areata-Like Phenotype: a clinical perspective. J Investig Dermatol Symp Proc 20(1):S58\u2013s59. https:\/\/doi.org\/10.1016\/j.jisp.2020.04.008","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"4004_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.gene.2013.05.086","volume":"527","author":"G Kalkan","year":"2013","unstructured":"Kalkan G, Karakus N, Ba\u015f Y et al (2013) The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population. Gene 527(2):565\u2013569. https:\/\/doi.org\/10.1016\/j.gene.2013.05.086","journal-title":"Gene"},{"issue":"11","key":"4004_CR56","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1600-0625.2011.01357.x","volume":"20","author":"JH Namkung","year":"2011","unstructured":"Namkung JH, Lee JE, Kim E et al (2011) Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population. Exp Dermatol 20(11):915\u2013919. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01357.x","journal-title":"Exp Dermatol"},{"issue":"9","key":"4004_CR57","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/jid.2012.129","volume":"132","author":"D Jagielska","year":"2012","unstructured":"Jagielska D, Redler S, Brockschmidt FF et al (2012) Follow-up study of the first genome-wide association scan in Alopecia Areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol 132(9):2192\u20132197. https:\/\/doi.org\/10.1038\/jid.2012.129","journal-title":"J Invest Dermatol"},{"issue":"1","key":"4004_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaci.2006.05.004","volume":"118","author":"S Weidinger","year":"2006","unstructured":"Weidinger S, Illig T, Baurecht H et al (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118(1):214\u2013219. https:\/\/doi.org\/10.1016\/j.jaci.2006.05.004","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"4004_CR59","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","volume":"127","author":"RC Betz","year":"2007","unstructured":"Betz RC, Pforr J, Flaquer A et al (2007) Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 127(11):2539\u20132543. https:\/\/doi.org\/10.1038\/sj.jid.5700915","journal-title":"J Invest Dermatol"},{"issue":"4","key":"4004_CR60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/exd.13336","volume":"27","author":"E Guttman-Yassky","year":"2018","unstructured":"Guttman-Yassky E, Krueger JG, Lebwohl MG (2018) Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Exp Dermatol 27(4):409\u2013417. https:\/\/doi.org\/10.1111\/exd.13336","journal-title":"Exp Dermatol"},{"issue":"3","key":"4004_CR61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40257-023-00838-9","volume":"25","author":"M Croft","year":"2024","unstructured":"Croft M, Esfandiari E, Chong C et al (2024) OX40 in the Pathogenesis of atopic Dermatitis-A New Therapeutic Target. Am J Clin Dermatol 25(3):447\u2013461. https:\/\/doi.org\/10.1007\/s40257-023-00838-9","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"4004_CR62","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jdermsci.2020.06.005","volume":"99","author":"H Nakagawa","year":"2020","unstructured":"Nakagawa H, Iizuka H, Nemoto O et al (2020) Safety, tolerability and efficacy of repeated intravenous infusions of KHK4083, a fully human anti-OX40 monoclonal antibody, in Japanese patients with moderate to severe atopic dermatitis. J Dermatol Sci 99(2):82\u201389. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.06.005","journal-title":"J Dermatol Sci"},{"issue":"2","key":"4004_CR63","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2018.11.053","volume":"144","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Pavel AB, Zhou L et al (2019) GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol 144(2):482\u2013493. https:\/\/doi.org\/10.1016\/j.jaci.2018.11.053","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"4004_CR64","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1111\/all.16268","volume":"79","author":"M Kim","year":"2024","unstructured":"Kim M, Del Duca E, Dahabreh D et al (2024) Alopecia Areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds. Allergy 79(12):3401\u20133414. https:\/\/doi.org\/10.1111\/all.16268","journal-title":"Allergy"},{"key":"4004_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00475","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer B, Paczesny S (2017) The ST2\/IL-33 Axis in Immune cells during inflammatory diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.00475","journal-title":"Front Immunol"},{"key":"4004_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20\u201338. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00624.x","journal-title":"Immunol Rev"},{"key":"4004_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107847","author":"AK Saikumar Jayalatha","year":"2021","unstructured":"Saikumar Jayalatha AK, Hesse L, Ketelaar ME, Koppelman GH, Nawijn MC (2021) The central role of IL-33\/IL-1RL1 pathway in asthma: from pathogenesis to intervention. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107847","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4004_CR68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","volume":"82","author":"AB Pavel","year":"2020","unstructured":"Pavel AB, Zhou L, Diaz A et al (2020) The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. J Am Acad Dermatol 82(3):690\u2013699. https:\/\/doi.org\/10.1016\/j.jaad.2019.10.039","journal-title":"J Am Acad Dermatol"},{"key":"4004_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225418","author":"A Wa\u015bkiel-Burnat","year":"2021","unstructured":"Wa\u015bkiel-Burnat A, Niemczyk A, Blicharz L et al (2021) Chemokine C-C motif Ligand 7 (CCL7), a biomarker of atherosclerosis, is Associated with the severity of Alopecia Areata: a preliminary study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10225418","journal-title":"J Clin Med"},{"issue":"10","key":"4004_CR70","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1111\/all.14814","volume":"76","author":"JW Glickman","year":"2021","unstructured":"Glickman JW, Dubin C, Dahabreh D et al (2021) An integrated scalp and blood biomarker approach suggests the systemic nature of Alopecia Areata. Allergy 76(10):3053\u20133065. https:\/\/doi.org\/10.1111\/all.14814","journal-title":"Allergy"},{"issue":"8","key":"4004_CR71","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ymthe.2022.04.019","volume":"30","author":"Q Tang","year":"2022","unstructured":"Tang Q, Sousa J, Echeverria D et al (2022) RNAi-based modulation of IFN-\u03b3 signaling in skin. Mol Therapy: J Am Soc Gene Therapy 30(8):2709\u20132721. https:\/\/doi.org\/10.1016\/j.ymthe.2022.04.019","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"5","key":"4004_CR72","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","volume":"98","author":"HA Miot","year":"2023","unstructured":"Miot HA, Criado PR, de Castro CCS, Ianhez M, Talhari C, Ramos PM (2023) JAK-STAT pathway inhibitors in dermatology. An Bras Dermatol 98(5):656\u2013677. https:\/\/doi.org\/10.1016\/j.abd.2023.03.001","journal-title":"An Bras Dermatol"},{"issue":"4","key":"4004_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17512433.2023.2193682","volume":"16","author":"A Muddebihal","year":"2023","unstructured":"Muddebihal A, Khurana A, Sardana K (2023) JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review. Expert Rev Clin Pharmacol 16(4):279\u2013295. https:\/\/doi.org\/10.1080\/17512433.2023.2193682","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"4004_CR74","doi-asserted-by":"publisher","first-page":"688","DOI":"10.25259\/ijdvl_8_2023","volume":"89","author":"SP Raychaudhuri","year":"2023","unstructured":"Raychaudhuri SP, Raychaudhuri SK (2023) JAK inhibitor: introduction. Indian J Dermatol Venereol Leprol 89(5):688\u2013690. https:\/\/doi.org\/10.25259\/ijdvl_8_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"4004_CR75","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM (2017) JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77(5):521\u2013546. https:\/\/doi.org\/10.1007\/s40265-017-0701-9","journal-title":"Drugs"},{"issue":"1","key":"4004_CR76","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Therapy 8(1):204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Therapy"},{"key":"4004_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","author":"IH Huang","year":"2022","unstructured":"Huang IH, Chung WH, Wu PC, Chen CB (2022) JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1068260","journal-title":"Front Immunol"},{"issue":"6","key":"4004_CR78","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jaci.2023.07.010","volume":"152","author":"E Guttman-Yassky","year":"2023","unstructured":"Guttman-Yassky E, Irvine AD, Brunner PM et al (2023) The role of Janus kinase signaling in the pathology of atopic dermatitis. J Allergy Clin Immunol 152(6):1394\u20131404. https:\/\/doi.org\/10.1016\/j.jaci.2023.07.010","journal-title":"J Allergy Clin Immunol"},{"key":"4004_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955035","author":"M Lensing","year":"2022","unstructured":"Lensing M, Jabbari A (2022) An overview of JAK\/STAT pathways and JAK inhibition in Alopecia Areata. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.955035","journal-title":"Front Immunol"},{"issue":"6","key":"4004_CR80","doi-asserted-by":"publisher","first-page":"799","DOI":"10.25259\/ijdvl_1093_2022","volume":"89","author":"RD Haughton","year":"2023","unstructured":"Haughton RD, Herbert SM, Ji-Xu A, Downing L, Raychaudhuri SP, Maverakis E (2023) Janus kinase inhibitors for Alopecia Areata: a narrative review. Indian J Dermatol Venereol Leprol 89(6):799\u2013806. https:\/\/doi.org\/10.25259\/ijdvl_1093_2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"11","key":"4004_CR81","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1111\/ijd.16316","volume":"61","author":"L Asfour","year":"2022","unstructured":"Asfour L, Getsos Colla T, Moussa A, Sinclair RD (2022) Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib. Int J Dermatol 61(11):e416\u2013e417. https:\/\/doi.org\/10.1111\/ijd.16316","journal-title":"Int J Dermatol"},{"issue":"4","key":"4004_CR82","doi-asserted-by":"publisher","first-page":"e15346","DOI":"10.1111\/dth.15346","volume":"35","author":"M Cantelli","year":"2022","unstructured":"Cantelli M, Martora F, Patruno C, Nappa P, Fabbrocini G, Napolitano M (2022) Upadacitinib improved Alopecia Areata in a patient with atopic dermatitis: a case report. Dermatol Ther 35(4):e15346. https:\/\/doi.org\/10.1111\/dth.15346","journal-title":"Dermatol Ther"},{"issue":"1s","key":"4004_CR83","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/der.0000000000000780","volume":"32","author":"A Gambardella","year":"2021","unstructured":"Gambardella A, Licata G, Calabrese G, De Rosa A, Alfano R, Argenziano G (2021) Dual efficacy of Upadacitinib in 2 patients with concomitant severe atopic dermatitis and Alopecia Areata. Dermatitis 32(1s):e85\u2013e86. https:\/\/doi.org\/10.1097\/der.0000000000000780","journal-title":"Dermatitis"},{"issue":"4","key":"4004_CR84","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/mop.0000000000000792","volume":"31","author":"JH Wu","year":"2019","unstructured":"Wu JH, Cohen BA (2019) The stigma of skin disease. Curr Opin Pediatr 31(4):509\u2013514. https:\/\/doi.org\/10.1097\/mop.0000000000000792","journal-title":"Curr Opin Pediatr"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:57:50Z","timestamp":1740067070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04004-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}